ArticleMaedica2026
Mycoplasma pneumoniae Infection in Children: Clinical Features and Outcomes.
Article in Maedica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Mycoplasma pneumoniae (MP) is a major cause of community-acquired respiratory infections, especially in school-aged children and young adults, with cyclical outbreaks occurring every few years. Material and methods: This study analyzed a cohort of pediatric patients treated in a tertiary hospital in Bucharest and compared the findings with data reported in the literature. Results: Elevated anti-MP antibody titers (IgG, IgA and IgM) were associated with increased leukocytosis, neutrophilia, complications and longer hospitalization. Fever, lobar involvement and complications were also linked to prolonged hospital stay. Conclusions: Our findings are consistent with international data and reflect the typical epidemiological profile of MP infection in children. These results contribute to the characterization of MP infection in the post-COVID era and support the need for prospective studies to validate the identified prognostic markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.